Post Categories
Advancing CRISPR-Based Treatment for Rare Swelling Disease
September 30, 2024
Intellia Therapeutics, based in Cambridge, Massachusetts, reported promising results from the Phase II clinical trial of NTLA-2002, a CRISPR-based therapy targeting hereditary angioedema (HAE),…
Advancing Phase 3 Trials for ADC Cancer Therapies
September 25, 2024
Antibody-drug conjugates (ADCs) are being studied in various diseases, including cancer, autoimmune and infectious diseases. In cancer, ADCs are made up of a monoclonal…
Battling COVID in the Lab: Mini-Lungs Yield Insights and Potential Prevention Pathways
September 23, 2024
Over the past five years, scientists have slowly gained a better understanding of SARS-CoV-2, the virus responsible for the COVID-19 pandemic. Despite our knowledge…
New Cancer Treatment Modality Goes into Phase I
September 18, 2024
Prostate cancer is the second most common cancer in men worldwide, making the search for effective treatments an urgent imperative for the medical community….
Breaking Ground in Cancer Treatment: First T-Cell Therapy Approved for Solid Tumors
September 16, 2024
Tecelra®, the first engineered T-cell therapy for solid tumors, has received approval from the Food and Drug Administration (FDA) for advanced MAGE-A4+ synovial sarcoma…
Medicare Price Cuts Promise Relief to Seniors
September 9, 2024
In a historic move, the White House announced steep price reductions for ten prescription drugs under Medicare thanks to the Inflation Reduction Act (IRA)….
Can Repeat Dosing with RNA Medicines Be Curative?
August 26, 2024
Exsilio Therapeutics, a Boston-based biotech startup, has secured $82 million in funding and hopes to target genetic conditions with a new approach to gene…
FDA Approves New Drug for Food Allergies
August 21, 2024
For individuals with life-threatening food allergies, everyday activities like dining out and traveling can be tremendously stressful, as even the smallest traces of the…
Game-Changing Drug for Colon Cancer May Redefine Treatment
August 19, 2024
Clinical trial results show that pembrolizumab, an immunotherapy drug used to treat multiple types of cancer, can dramatically improve outcomes for patients with colorectal…
Using Brain Waves to Detect Pain
August 14, 2024
Chronic pain affects more than one-quarter of adults in the United States. This debilitating level of pain is difficult to treat for a number…
RNAi Breakthrough in Heart Disease Treatment
August 12, 2024
Alnylam Pharmaceuticals, which specializes in developing RNA interference (RNAi) therapeutics to treat genetic diseases, has announced promising clinical trial results for their drug Amvuttra®…
How Genetics Helped Solve the Mystery of the Ultra-Rare Brown Panda
August 7, 2024
While China’s black and white pandas are famous as symbols of diplomacy and conservation, their lesser-known and extremely rare brown and white relatives have…
Squid-Inspired Microjet Device Could Enable More Direct Drug Delivery
February 3, 2025
A new type of drug delivery device in development could someday bypass the challenges and fears associated with certain types of injectable drugs. In…
Tiny Treadmills: Vampire Bats on the Go
January 29, 2025
In most mammals, the act of running is fueled primarily by the oxidization of carbohydrates and lipids, which are stored in the body as…
A Shot at Ending HIV: The Promise of Lenacapavir
January 27, 2025
HIV remains a global health crisis, infecting more than 1 million people annually. Although research has advanced to treat people who become infected, a…
Whale Clicks and Crow Caws: Can AI Help Humans Understand Animal Communication?
January 20, 2025
Artificial intelligence (AI) is reshaping how we understand the natural world. By decoding the sounds of animals—whale clicks, elephant rumbles, or crow caws—scientists hope…
An Unintended Consequence of Intermittent Fasting: Reduced Hair Growth
January 15, 2025
Intermittent fasting is quickly becoming one of the most popular dietary adjustments around the world. Less of a “diet” and more of a “dietary…
Encouraging Preclinical Results Show Gene Therapy Reduces Seizures
January 13, 2025
California-based Capsida Biotherapeutics has reported promising preclinical results for CAP-002, its gene therapy for developmental and epileptic encephalopathy (DEE) caused by mutations in the…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
QPS Selects Ryght AI as an Exclusive AI Partner for Clinical Trial Optimization and Automation while adding to Ryght’s global site network. Laguna Beach,…
